Skip to main content

Our industries

Pharmaceutical, healthcare and life sciences

We are recognised as a leading advisor for patent prosecution and litigation, corporate and licensing work in the pharmaceutical, healthcare and life sciences sectors.

Our pharmaceutical, healthcare and life sciences team stays up-to-date with the rapidly changing landscape of these innovative sectors, advising research institutions, healthcare providers, medical device companies and major pharmaceutical players on the full spectrum of their legal concerns, including regulatory issues such as product registration, clinical trial regulation and marketing authorization applications.

Our IP expertise is designed to protect all aspects of our client’s portfolios. We advise on one-off filings, prosecution and litigation and assist with all aspects of our client’s IP strategies. Our expertise encompasses the full range of patents, trademarks and copyrights. Our clients are prominent international household names with diverse IP portfolios and leading local clients with strong brands nationally and in the region.

We handle various pharmaceutical, healthcare and life sciences advisory work, including compliance, risk management, and dispute resolution. Our experts also regularly defend doctors against malpractice claims, including Medicare/Medicaid and healthcare fraud and abuse. The team benefits from the presence of experienced medical, coding and billing experts.

Practice areas
  • Drugs manufacturing and distribution
  • Product licensing
  • Regulatory compliance
  • Commercial
At a glance
  • Novartis Pharma Pakistan Limited: represented the client in suits and thereafter appeals filed by ex-employees before the District Courts and the High Court of Sindh bench at Larkana.
  • Pakistan Chemists and Druggists Association: represented client and obtained an interim order restraining the operation of section 7 of the import pricing policy as issued by the Drug Regulatory Authority of Pakistan on behalf of the Defending American Life Insurance Company (Pakistan) Limited (ALICO Pakistan) (now known as IGI Life Insurance Limited) and American Life Insurance Company (ALICO) in two suits filed before the High Court of Sindh at Karachi by employees of American Life Insurance Company (Pakistan) Limited, against the intended sale of ALICO’s majority shareholding in ALICO Pakistan, to IGI Insurance Limited.
  • Pfizer Corporation: represented the client in the restructuring and merger of its subsidiaries in Pakistan.
  • Searle IV Solutions: represented client, one of the leading pharmaceutical companies of Pakistan manufacturing lifesaving IV solutions, in a suit relating to whether an S.R.O granting a tax exemption applied to the material imported by Searle.

Speak to lead pharmaceutical, healthcare and life sciences partner Mayhar Kazi today.

Stay in touch

Subscribe to our newsletter

Stay in touch
Sending

News/Insight

  • Importance of a name – RIAA wins dismissal of PKR 425 million suit

    The concept of legal personality lies at the heart of the law. Legal persons are the subjects of legal relationships, which confer rights and impose obligations. Most obviously, the law recognizes individuals as natural perso


    Read more

  • RIAA Defends Leading Battery Manufacturer in Tax Fraud FIRs

    We are representing a leading automotive battery manufacturer in tax fraud FIRs filed by the Federal Board of Revenue (FBR). The automotive battery sector is one of the five industries Read more

  • Sindh High Court grants injunction in shipping shortage claim case

    The Sindh High Court recently granted an interim injunction restraining the civil court from passing judgment in suits alleging short landing of imported edible oil cargoes. The injunction, secured by RIAA Barker Gillette on


    Read more

  • RIAA challenges denial of concessional customs duty for pharma industry

    We represent a global consumer healthcare and pharmaceutical industry leader in a complex customs duty dispute before the Sindh High Court. The case challenges the denial of concessionary customs duty rates on materials requi


    Read more

  • Pakistan Public Private Partnership Laws 2025

    We authored the Read more

What clients say...

  • Chambers Asia Pacific 2022
    "RIAA are responsive, professional and polite in explaining their advice, well researched in their opinions, and reliable in their response time… they also share commercial and operational consequences of the options presented in their advice. We are very happy with their support…." - Chambers Asia Pacific 2022

  • The Legal 500 2022
    “RIAA has an excellent litigation practice that advises on the full range of contentious issues as well as international arbitrations. The practice regularly handles all forms of civil, commercial, corporate, regulatory and white-collar crime matters before all the courts in Pakistan. It has extensive experience in a diverse range of industry sectors …” – The Legal 500 2022

  • Chambers Asia Pacific 2022
    "We find them to be extremely professional and responsive. They are meticulous in raising all the right legal points but at the same time are very solution-oriented in helping to structure the transactions in the right way to fully protect our legal rights." – Chambers Asia Pacific 2022

  • The Legal 500 2022
    “The team has an excellent track record of working on some of the most significant projects in Pakistan throughout the years.” – The Legal 500 2022 

  • Legal 500 2021
    We have worked with RIAA Barker Gillette for many years on a number of matters, including regulatory issues, labor, general corporate, competition law, and tax matters…..We have found high-quality lawyers across disciplines, who are able to balance the requirement for technically sound advice while also being practical and solution-orientated - Legal 500 2021

Read more